{
  "id": 13271211,
  "title": "Cerence CFO Antonio Rodriguez sells $612,912 in company stock",
  "url": "https://urgent.news/2026/10/10/cerence-cfo-antonio-rodriguez-sells-612-912-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-10T00:30:51.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/cerence-cfo-antonio-rodriguez-sells-612912-in-company-stock-93CH-4941892"
  },
  "original_language": "en",
  "account": "Cerence Inc.'s CFO Antonio Rodriguez recently sold 76,614 shares of the company's stock on October 7, 2026. The transaction, totaling $612,912, was executed to satisfy tax withholding obligations tied to the vesting of restricted stock units. Rodriguez's shares were sold at $8 per share, a price that currently puts the stock at $8.44. Despite the company's impressive gross profit margins of 78.69%, financial analysts have noted the stock's volatility. In February 2026, Rodriguez had purchased 2,000 shares through Cerence's Employee Stock Purchase Plan at $7.02 per share, bringing his current total holdings to 500,632 shares. Cerence's recent fiscal third-quarter 2026 report showed adjusted earnings of $0.03 per share on $69.6 million in revenue, falling short of Wall Street's expectations. The company, however, outperformed its own adjusted EBITDA and free cash flow projections. These earnings results have sparked investor debate about Cerence's financial health, with analysts' opinions potentially shaping future market sentiment.",
  "summary": null,
  "key_points": [
    "CFO Antonio Rodriguez sold $612,912 worth of Cerence stock on October 7, 2026.",
    "Transaction executed to meet tax obligations from restricted stock vesting.",
    "Rodriguez held 500,632 shares after the sale, purchased at $7.02 per share."
  ],
  "editors_take": "The sale of Cerence stock by CFO Antonio Rodriguez to cover tax obligations does not necessarily signal a loss of confidence in the company's financial health despite analysts' debate on its stability.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}